BioCrossroads

Established in 2003, BioCrossroads is a Central Indiana Corporate Partnership (CICP) initiative that grows, advances, and invests in Indiana’s life sciences industry, which generates $77 billion in economic activity statewide. To support this sector, which includes biosciences, drugs and pharmaceuticals, medical devices and equipment, research, testing, and medical laboratories, and health information technology, the organization engages in the following activities: investing in life sciences businesses through mentorship and venture capital funds; expanding collaboration and partnerships among Indiana’s life sciences institutions; promoting science education; marketing Indiana’s life sciences industry; and launching new life sciences enterprises. 

These activities led to the creation of several BioCrossroads-affiliated nonprofits. In 2004, the Indiana Health Information Exchange (IHIE) was established to provide secure, interoperable health IT network to connect hospitals, care facilities, health clinics, and other healthcare providers. Two years later, the Datalys Center for Sports Injury Research and Prevention was formed. The center, which focuses on the health and safety of athletes and other physically active populations, is a collaborative effort between BioCrossroads, the National Collegiate Athletic Association (NCAA), and the American Academy of Sports Medicine.

BioCrossroadsLINX was established in 2007 to advance Indiana’s drug development sector and facilitate connections with the biotechnology and pharmaceutical industries. It is a partnership of academic, government, and industry leaders, including BioCrossroads, Cook Medical, the Indiana Department of Workforce Development (DWD), Indiana Economic Development Corporation, Ivy Tech Community College, and Purdue University.

In 2009, OrthoWorx was created to preserve and advance Warsaw, Indiana’s, legacy as “The Orthopedic Capital of the World.” Initial funding for this initiative was provided by Lilly Endowment, Inc.

Finally, the Indiana Biosciences Research Institute (IBRI) was formed in 2013 to enable discovery and innovation in the life sciences through collaborations with academic, corporate, government, and philanthropic organizations, including Indiana University, Purdue University, University of Notre Dame, IU Health, Regenstrief Institute, Eli Lilly and Company, Cook Medical, Corteva Agriscience, and Roche Diagnostics. IBRI has dedicated a large portion of its resources to projects addressing metabolic diseases, including diabetes, cardiovascular disease, obesity, and poor nutrition.

In addition to supporting these nonprofits, BioCrossroads hosts the Indiana Life Sciences Summit. This annual event, established in 2003, is the state’s largest life sciences conference and networking event that brings in thought leaders from around the world to discuss industry trends and developments.

BioCrossroads moved into the 16 Tech Innovation Center on Waterway Boulevard in 2020.